Humanized dopamine D4.7 receptor male mice display risk‐taking behavior and deficits of social recognition and working memory in light/dark‐dependent manner

Amal Alachkar,Alvin Phan,Travis Dabbous,Sammy Alhassen,Wedad Alhassen,Bryan Reynolds,Marcelo Rubinstein,Sergi Ferré,Olivier Civelli
DOI: https://doi.org/10.1002/jnr.25299
IF: 4.433
2024-02-06
Journal of Neuroscience Research
Abstract:We explored the behavior of mice in relation to dopamine‐receptor D4 (DRD4) gene, focusing on the D4.7R variant associated with attentional traits in humans. By conducting behavioral assays and analyzing DRD4 expression patterns at different times of the day, we have identified potential associations between light–dark cycle, genetic variations, and behavioral phenotypes. The dopamine D4 receptor 7‐repeat allele (D4.7R) has been linked with psychiatric disorders such as attention‐deficit–hyperactivity disorder, autism, and schizophrenia. However, the highly diverse study populations and often contradictory findings make it difficult to draw reliable conclusions. The D4.7R has the potential to explain individual differences in behavior. However, there is still a great deal of ambiguity surrounding whether it is causally connected to the etiology of psychiatric disorders. Therefore, humanized D4.7R mice, with the long third intracellular domain of the human D4.7R, may provide a valuable tool to examine the relationship between the D4.7R variant and specific behavioral phenotypes. We report that D4.7R male mice carrying the humanized D4.7R variant exhibit distinct behavioral features that are dependent on the light–dark cycle. The behavioral phenotype was characterized by a working memory deficit, delayed decision execution in the light phase, decreased stress and anxiety, and increased risk behavior in the dark phase. Further, D4.7R mice displayed impaired social recognition memory in both the light and dark phases. These findings provide insight into the potential causal relationship between the human D4.7R variant and specific behaviors and encourage further consideration of dopamine D4 receptor (DRD4) ligands as novel treatments for psychiatric disorders in which D4.7R has been implicated.
neurosciences
What problem does this paper attempt to address?